Cas:34243-38-4 2-thiophen-2-yl-1,3-benzothiazole manufacturer & supplier

Chemical Name:2-thiophen-2-yl-1,3-benzothiazole

CAS.NO:34243-38-4

Synonyms:2-(1H-IMIDAZOL-1-YL)-1-PROPANOL;2-(2-thienyl)-1,3-benzothiazole;2-(thiophen-2-yl)benzothiazole;2-(2-benzothiazolyl)thiophene;2-(thiophen-2-yl)benzo[d]thiazole;2-(2-Thienyl)benzothiazole;2-(2-thiophenyl)benzo[d]thiazole;benzothiazole,2-(2-thienyl);2-thienyl-1,3-benzothiazole

Molecular Formula:C₁₁H₇NS₂

Molecular Weight:217.31000

HS Code:2934999090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:368.8ºC at 760mmHg

Density:1.349g/cm3

Index of Refraction:1.719

PSA:69.37000

Exact Mass:217.00200

LogP:4.02480

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2-(1H-IMIDAZOL-1-YL)-1-PROPANOL chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-thienyl-1,3-benzothiazole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-(thiophen-2-yl)benzo[d]thiazole Use and application,2-thienyl-1,3-benzothiazole technical grade,usp/ep/jp grade.

Related News: Active Pharmaceutical Ingredients (APIs): Pharmaceutical active ingredients, which are the basic substances that constitute the pharmacological effects of pharmaceuticals, and are prepared by chemical synthesis, plant extraction, or biotechnology. 2-thiophen-2-yl-1,3-benzothiazole manufacturer Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. 2-thiophen-2-yl-1,3-benzothiazole supplier Ultimately there’s likely a broad mix of social, cultural and economic drivers at play, suggested Lona Sandon, program director of the Department of Clinical Nutrition in the School of Health Professions at the UT Southwestern Medical Center in Dallas. She was not part of the research. 2-thiophen-2-yl-1,3-benzothiazole vendor It found that about 5% of both groups of women have a genetic mutation that increases the risk of breast cancer. 2-thiophen-2-yl-1,3-benzothiazole factory Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.